^
Association details:
| Biomarker: | BCL2 expression |
|---|---|
| Cancer: | Hodgkin Lymphoma |
| Regimen: | ABVD (bleomycin + dacarbazine + doxorubicin hydrochloride + vinblastine) |
| Direction: | Resistant |
Evidence:
Source:
Title:
ACTIVATED CASPASE-3 EXPRESSION BY HODGKIN AND REED-STERNBERG CELLS (HRS) IS A POWERFUL PROGNOSTIC FACTOR IN CLASSICAL HODGKIN LYMPHOMA (CHL) TREATED WITH ABVD OR EQUIVALENT REGIMENS
Published date:
05/17/2018
Excerpt:
Eligible patients had biopsy-proven cHL treated with ABVD or equivalent regimens...BCL2 expression also correlated with inferior FFP (p=0.004).
